Novartis AG

Novartis AG Beats on EPS, Stock Down 1.64%

Novartis reported an EPS that exceeded expectations, but the stock still fell by 1.64% after the earnings announcement. This decline could indicate investor concerns about other aspects of the company's performance or future outlook, especially since revenue figures were not disclosed. The lack of guidance further adds uncertainty for investors.